Onex Canada Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,469
| Closed | -$932K | – | 123 |
|
|
2025
Q1 | $932K | Sell |
1,469
-750
| -34% | -$476K | 0.12% | 110 |
|
|
2024
Q4 | $1.58M | Sell |
2,219
-15
| -0.7% | -$10.7K | 0.19% | 97 |
|
|
2024
Q3 | $2.35M | Hold |
2,234
| – | – | 0.27% | 87 |
|
|
2024
Q2 | $2.35M | Buy |
2,234
+4
| +0.2% | +$4.2K | 0.27% | 100 |
|
|
2024
Q1 | $2.15M | Sell |
2,230
-202
| -8% | -$194K | 0.21% | 110 |
|
|
2023
Q4 | $2.14M | Sell |
2,432
-779
| -24% | -$684K | 0.21% | 117 |
|
|
2023
Q3 | $2.64M | Sell |
3,211
-408
| -11% | -$336K | 0.2% | 114 |
|
|
2023
Q2 | $2.6M | Sell |
3,619
-974
| -21% | -$700K | 0.16% | 119 |
|
|
2023
Q1 | $3.77M | Sell |
4,593
-2,239
| -33% | -$1.84M | 0.21% | 103 |
|
|
2022
Q4 | $4.93M | Buy |
6,832
+162
| +2% | +$117K | 0.28% | 96 |
|
|
2022
Q3 | $4.6M | Sell |
6,670
-65
| -1% | -$44.8K | 0.27% | 92 |
|
|
2022
Q2 | $3.98M | Sell |
6,735
-68
| -1% | -$40.2K | 0.22% | 103 |
|
|
2022
Q1 | $4.75M | Buy |
+6,803
| New | +$4.75M | 0.21% | 104 |
|